⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
BNTX News
BioNTech SE American Depositary Share
Pancreatic Cancer Market Set to Expand During the Forecast Period (2025-2034) as Precision Medicine and Immunotherapy Transform Treatment Landscape | DelveInsight
prnewswire.com
BNTX
NVCR
ONCO
AZN
MRK
MRUS
Undisclosed Deaths in the Pfizer mRNA COVID-19 Vaccine Trial Discussed in the Journal of American Physicians and Surgeons
globenewswire.com
PFE
BNTX
MRNA
Immunostimulant Market to Reach $288.82 billion, Globally, by 2034 at 9.9% CAGR: Allied Market Research
prnewswire.com
MRK
PFE
BNTX
BMY
AMGN
MRNA
BioNTech and Bristol Myers Squibb Present First Global Phase 2 Data for PD-L1xVEGF-A Bispecific Antibody Pumitamig Showing Encouraging Efficacy in Advanced Triple-Negative Breast Cancer
globenewswire.com
BNTX
BMY
Global Peptide Synthesis Market Set to Reach USD 1.41 Billion by 2029 | MarketsandMarkets™
globenewswire.com
BNTX
MRNA
TMO
A
CC
BioNTech and OncoC4 Announce Clinically Meaningful Overall Survival Benefit for Selective Treg Modulator Gotistobart in Patients with Previously Treated Squamous Non-Small Cell Lung Cancer
globenewswire.com
BNTX
BioNTech Achieves Minimum Condition in CureVac Exchange Offer
globenewswire.com
BNTX
CVAC
Antitumor ADC Drugs Market Forecast Shows Strong 12.86% CAGR Through 2035
globenewswire.com
PFE
AZN
DSNKY
GILD
IMMU
REGN
BIIB
BMY
MRK
NVS
AMGN
LLY
JNJ
ABBV
BNTX
SEGN
RHHBY
Takeda
IQV
PE
BioNTech Shares Progress on Exchange Offer for CureVac Shares and Highlights December 3, 2025, at 9:00 a.m. Eastern Time Expiration
globenewswire.com
BNTX
CVAC
mRNA Vaccines Market Forecast 2025-2032 | Industry to Double in Size | Regulatory Fast Track Approvals and Adaptive Licensing Frameworks Accelerating Next Generation mRNA Vaccines - ResearchAndMarkets.com
businesswire.com
PFE
MRNA
BNTX